BUB1 and hepatocellular carcinoma: An inhibition of BUB1 Mitotic Checkpoint Serine/Threonine Kinase (BUB1) by miR-490 was observed in various in vitro models resulting in a modulation of TGFβ/SMAD signaling pathways to reduce HCC cell proliferation, migration, as well as invasion [164].